TY - JOUR
T1 - Advances in Cardiac Electrophysiology
AU - Piccini, Jonathan P.
AU - Russo, Andrea M.
AU - Sharma, Parikshit S.
AU - Kron, Jordana
AU - Tzou, Wendy
AU - Sauer, William
AU - Park, David S.
AU - Birgersdotter-Green, Ulrika
AU - Frankel, David S.
AU - Healey, Jeff S.
AU - Hummel, John
AU - Koruth, Jacob
AU - Linz, Dominik
AU - Mittal, Suneet
AU - Nair, Devi G.
AU - Nattel, Stanley
AU - Noseworthy, Peter A.
AU - Steinberg, Benjamin A.
AU - Trayanova, Natalia A.
AU - Wan, Elaine Y.
AU - Wissner, Erik
AU - Zeitler, Emily P.
AU - Wang, Paul J.
N1 - Publisher Copyright:
© 2022 Lippincott Williams and Wilkins. All rights reserved.
PY - 2022/12/1
Y1 - 2022/12/1
N2 - Despite the global COVID-19 pandemic, during the past 2 years, there have been numerous advances in our understanding of arrhythmia mechanisms and diagnosis and in new therapies. We increased our understanding of risk factors and mechanisms of atrial arrhythmias, the prediction of atrial arrhythmias, response to treatment, and outcomes using machine learning and artificial intelligence. There have been new technologies and techniques for atrial fibrillation ablation, including pulsed field ablation. There have been new randomized trials in atrial fibrillation ablation, giving insight about rhythm control, and long-term outcomes. There have been advances in our understanding of treatment of inherited disorders such as catecholaminergic polymorphic ventricular tachycardia. We have gained new insights into the recurrence of ventricular arrhythmias in the setting of various conditions such as myocarditis and inherited cardiomyopathic disorders. Novel computational approaches may help predict occurrence of ventricular arrhythmias and localize arrhythmias to guide ablation. There are further advances in our understanding of noninvasive radiotherapy. We have increased our understanding of the role of His bundle pacing and left bundle branch area pacing to maintain synchronous ventricular activation. There have also been significant advances in the defibrillators, cardiac resynchronization therapy, remote monitoring, and infection prevention. There have been advances in our understanding of the pathways and mechanisms involved in atrial and ventricular arrhythmogenesis.
AB - Despite the global COVID-19 pandemic, during the past 2 years, there have been numerous advances in our understanding of arrhythmia mechanisms and diagnosis and in new therapies. We increased our understanding of risk factors and mechanisms of atrial arrhythmias, the prediction of atrial arrhythmias, response to treatment, and outcomes using machine learning and artificial intelligence. There have been new technologies and techniques for atrial fibrillation ablation, including pulsed field ablation. There have been new randomized trials in atrial fibrillation ablation, giving insight about rhythm control, and long-term outcomes. There have been advances in our understanding of treatment of inherited disorders such as catecholaminergic polymorphic ventricular tachycardia. We have gained new insights into the recurrence of ventricular arrhythmias in the setting of various conditions such as myocarditis and inherited cardiomyopathic disorders. Novel computational approaches may help predict occurrence of ventricular arrhythmias and localize arrhythmias to guide ablation. There are further advances in our understanding of noninvasive radiotherapy. We have increased our understanding of the role of His bundle pacing and left bundle branch area pacing to maintain synchronous ventricular activation. There have also been significant advances in the defibrillators, cardiac resynchronization therapy, remote monitoring, and infection prevention. There have been advances in our understanding of the pathways and mechanisms involved in atrial and ventricular arrhythmogenesis.
KW - arrhythmias, cardiac
KW - atrial fibrillation
KW - cardiac electrophysiology
KW - defibrillators, implantable
KW - tachycardia, ventricular
UR - http://www.scopus.com/inward/record.url?scp=85144145722&partnerID=8YFLogxK
U2 - 10.1161/CIRCEP.121.009911
DO - 10.1161/CIRCEP.121.009911
M3 - Review article
C2 - 36441565
AN - SCOPUS:85144145722
SN - 1941-3149
VL - 15
SP - E009911
JO - Circulation: Arrhythmia and Electrophysiology
JF - Circulation: Arrhythmia and Electrophysiology
IS - 12
ER -